ImmunityBio (26CA.F) Q2 2024 Earnings

9MayConfirmed
Q4 2023
Q2 2024
-0.33
-0.28
-0.22
-0.17

Details

Expected EPS
-0.18080400000000002
Actual EPS
-0.166896
Surprise EPS
0.01
Surprise Percent
+7.69%

Description

ImmunityBio (26CA.F) has reported earnings of -0.166896 per share for Q2 2024.

0 Comments

Share your thoughts